Florfenicol, Terbinafine, Mometasone

14 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1430.0%

Death Rate

Active Ingredients

Florfenicol, Terbinafine, Mometasone

Administration Routes

Auricular (Otic)UnknownTopical

Species Affected

Dog 14

Most Affected Breeds

Bulldog - French 2

Maltese 2

Retriever - Labrador 2

Terrier - Yorkshire 1

American Pit Bull Terrier 1

Poodle - Toy 1

Greater Swiss Mountain Dog 1

Boxer (German Boxer) 1

Terrier (unspecified) 1

Shepherd Dog - German 1

Most Reported Reactions

Ear infection NOS 4

Lack of efficacy - NOS 3

Inappropriate urination 3

Tachycardia 3

Decreased drinking 3

Elevated serum alkaline phosphatase (ALP) 3

Prescribing error 3

Stenotic ear canal 3

Proteinuria 2

Blood and lymphatic system disorder NOS 2

Disorder of red blood cell NOS 2

Hyperproteinaemia 2

Outcome Breakdown

Outcome Unknown

5 (35.7%)

Ongoing

4 (28.6%)

Recovered/Normal

3 (21.4%)

Euthanized

2 (14.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.